.RESEARCH STUDY FEATURE.06 August 2024.
A large randomized measured test along with cisgender girls highlights the obstacles of adherence to a daily oral preexposure prevention regiment as well as shows that twice-yearly shot of lenacapavir can easily sustain efficient HIV prevention degrees over 6 months.